海尔谭丽霞：以女性智慧点亮全球生命之光

Group 1 - The core viewpoint is that the Chinese health industry is reshaping the global landscape at twice the global growth rate, driven by policy foundations, aging population demands, and consumption upgrades, creating a trillion-yuan innovation testing ground [1][2] - The total revenue scale of China's health industry is expected to approach 9 trillion yuan by 2024, with Shandong province playing a significant role as an innovative leader in the pharmaceutical and health industry [2] - The company, Yinkang Yisheng, has focused on breakthroughs in science and technology, digital empowerment, and global leadership strategies, building a health ecosystem driven by technology and intelligence [2] Group 2 - Yinkang Yisheng is addressing global challenges such as biological safety, disease prevention, resource accessibility, and health equity by initiating projects for early prevention of breast cancer, early intervention for autism, and research on neurodegenerative diseases [2] - The company has established the "Haiyi Hui" platform to accelerate the transformation of medical technology in fields like brain science, blood ecology, and immune ecology, promoting technological inclusivity and clinical innovation [2] - The unique sensitivity and resilience of women are seen as extraordinary strengths in the pursuit of health, with a call for more female business leaders to participate in this mission [3]